Xiaojuan W. Yang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Review Article: Systemic Treatments for Advanced Cholangiocarcinoma-State of the Art and Future Directions.
Journal: Alimentary pharmacology & therapeutics
Published: March 09, 2026
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression.
Journal: Current oncology (Toronto, Ont.)
Published: February 11, 2026
Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications.
Journal: Molecular cancer
Published: January 21, 2026
Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515).
Journal: Signal transduction and targeted therapy
Published: January 07, 2026
Discovery of novel olaparib-β-carboline hybrids for treating BRCA-deficient triple negative breast cancer.
Journal: Bioorganic & medicinal chemistry
Published: December 01, 2025
Recent progress of napabucasin as privileged scaffold in the discovery of anticancer agents.
Journal: European journal of medicinal chemistry
Published: September 27, 2025
SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repair.
Journal: Oncogene
Published: August 06, 2025
A Circular RNA Promotes Tumor Metastasis through Stabilizing MSI2 Protein in Pancreatic Ductal Adenocarcinoma.
Journal: Research (Washington, D.C.)
Published: June 08, 2025
Irradiation-induced increase in nuclear p62 levels contributes to chromosomal fragmentation and chromothripsis.
Journal: International journal of surgery (London, England)
Published: May 24, 2025
Targeting ubiquitination in disease and therapy.
Journal: Signal transduction and targeted therapy
Published: April 04, 2025
Last Updated: 09/26/2026